Company / Operating Income
Coherus Oncology, Inc. Operating Income History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$107.8M
FY2019
5-year range
-$232.1M / $107.8M
FY2015-FY2019
Trend
+152.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$232M to $108M over the past 2 years.
Based on SEC 10-K filings.
$108M in FY2019.
Improved from -$232M to $108M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income increased 152.7% year-over-year.
- Lowest operating income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $107.8M | +152.7% |
| FY2018 | -$204.4M | +11.9% |
| FY2017 | -$232.1M | -258.9% |
| FY2016 | -$64.7M | -79.7% |
| FY2015 | -$36.0M | +6.6% |
| FY2014 | -$38.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026